Pages that link to "Q36808420"
Jump to navigation
Jump to search
The following pages link to Biomarkers for detection and surveillance of bladder cancer. (Q36808420):
Displaying 50 items.
- Potential new urinary markers in the early detection of bladder cancer (Q33657098) (← links)
- FGFR3, HRAS, KRAS, NRAS and PIK3CA mutations in bladder cancer and their potential as biomarkers for surveillance and therapy. (Q33745140) (← links)
- Aminopeptidase activities as prospective urinary biomarkers for bladder cancer (Q33762931) (← links)
- Urotensin II receptor determines prognosis of bladder cancer regulating cell motility/invasion (Q33772333) (← links)
- Oncoprotein DEK as a tissue and urinary biomarker for bladder cancer (Q33929637) (← links)
- ROS generation via NOX4 and its utility in the cytological diagnosis of urothelial carcinoma of the urinary bladder (Q34059983) (← links)
- Fluorescence in situ hybridization for detecting urothelial carcinoma: a clinicopathologic study (Q34361348) (← links)
- Urinary levels of hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein as a diagnostic biomarker in patients with bladder cancer (Q34401768) (← links)
- Developing urinary metabolomic signatures as early bladder cancer diagnostic markers (Q34802622) (← links)
- A pilot study combining a GC-sensor device with a statistical model for the identification of bladder cancer from urine headspace (Q34828645) (← links)
- Inhibition of Lon blocks cell proliferation, enhances chemosensitivity by promoting apoptosis and decreases cellular bioenergetics of bladder cancer: potential roles of Lon as a prognostic marker and therapeutic target in baldder cancer (Q34957287) (← links)
- A robust methodology to study urine microRNA as tumor marker: microRNA-126 and microRNA-182 are related to urinary bladder cancer (Q34976475) (← links)
- Bladder cancer screening in aluminum smelter workers (Q35219579) (← links)
- The direct anti-cancer effect of a single instillation of epirubicin after transurethral resection of bladder tumor for non-muscle-invasive bladder cancer (Q35775435) (← links)
- Organ Specific Tumor Markers: What's New? (Q35980584) (← links)
- Epigenetic alterations in bladder cancer and their potential clinical implications. (Q36095721) (← links)
- Diagnosis of bladder cancer by immunocytochemical detection of minichromosome maintenance protein-2 in cells retrieved from urine (Q36387900) (← links)
- Urinary APE1/Ref-1: A Potential Bladder Cancer Biomarker. (Q36556271) (← links)
- Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer (Q37085946) (← links)
- NMP22 is predictive of recurrence in high-risk superficial bladder cancer patients (Q37472494) (← links)
- Diagnostic utility of double immunostaining of a urine cytology preparation for cytokeratin 20/p53 expression in a young woman with micropapillary urothelial carcinoma of the renal pelvis presenting as an unknown primary malignancy (Q37472535) (← links)
- A review on the current state of urine cytology emphasizing the role of fluorescence in situ hybridization as an adjunct to diagnosis (Q37781786) (← links)
- Digitized microscopy in the diagnosis of bladder cancer: analysis of >3000 cases during a 7-month period (Q37853965) (← links)
- Diagnostic evaluation of urinary angiogenin (ANG) and clusterin (CLU) as biomarker for bladder cancer (Q39216992) (← links)
- Point-of-Care Tests for Bladder Cancer: The Influencing Role of Hematuria (Q39480653) (← links)
- Silencing USP22 by asymmetric structure of interfering RNA inhibits proliferation and induces cell cycle arrest in bladder cancer cells (Q39658259) (← links)
- Urovysion: Considerations on modifying current evaluation scheme, including immunophenotypic targeting and locally set, statistically derived diagnostic criteria (Q39763864) (← links)
- Prognostic value of urinary cytology and other biomarkers for recurrence and progression in bladder cancer: a prospective study (Q40893287) (← links)
- Identification of genes correlated with early-stage bladder cancer progression (Q40897221) (← links)
- Diagnostic and Prognostic Significance of Serum and Tissue Galectin 3 Expression in Patients with Carcinoma of the Bladder (Q41661749) (← links)
- Microplate magnetic chemiluminescence immunoassay for detecting urinary survivin in bladder cancer (Q41701956) (← links)
- Is the performance of urinary cytology as high as reported historically? A contemporary analysis in the detection and surveillance of bladder cancer (Q42687457) (← links)
- Ubiquilin2 as a novel marker for detection of urothelial carcinoma cells in urine (Q46680025) (← links)
- Investigating Colorimetric Protein Array Assay Schemes for Detection of Recurrence of Bladder Cancer (Q48175687) (← links)
- Comparison of different concepts for interpretation of chromosomal aberrations in urothelial cells detected by fluorescence in situ hybridization. (Q48914536) (← links)
- BCAN Think Tank session 2: Molecular detection of bladder cancer: the path to progress (Q51145043) (← links)
- Combined application of cytology and molecular urine markers to improve the detection of urothelial carcinoma (Q51297927) (← links)
- [Expression of the tumormarker p16INK4a in cytology specimens of the urinary bladder. A new means for early recognition and surveillance of urothelial cancer]. (Q54567412) (← links)
- Performance of Urinary Markers for Detection of Upper Tract Urothelial Carcinoma: Is Upper Tract Urine More Accurate than Urine from the Bladder? (Q55286854) (← links)
- Does urinary cytology have a role in haematuria investigations? (Q61307725) (← links)
- Effectiveness of bladder tumor antigen quantitative test in the diagnosis of bladder carcinoma in a schistosoma endemic area (Q64098336) (← links)
- The role of oncostatin M receptor gene polymorphisms in bladder cancer (Q64237051) (← links)
- Comparison of urinary cytology and fluorescence in situ hybridization in the detection of urothelial neoplasia: An analysis of discordant results. (Q64954033) (← links)
- Cell-free DNA in blood and urine as a diagnostic tool for bladder cancer: a meta-analysis. (Q64967110) (← links)
- Urinary cytology and molecular markers (Q82339581) (← links)
- Microsatellite markers and methylation of promoters of tumour suppressor genes in bladder cancer (Q82339600) (← links)
- Impact of different grades of microscopic hematuria on the performance of urine-based markers for the detection of urothelial carcinoma (Q82747417) (← links)
- Influence of urinary tract instrumentation and inflammation on the performance of urine markers for the detection of bladder cancer (Q83563654) (← links)
- Preliminary study of diagnostic utility of molecular beacons in bladder cancer (Q84480689) (← links)
- Individual risk assessment in bladder cancer patients based on a multi-marker panel (Q84795934) (← links)